Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

T

Technische Universität Dresden

Status

Completed

Conditions

Healthy Subjects

Treatments

Drug: atorvastatin
Drug: irbesartan

Study type

Interventional

Funder types

Other

Identifiers

NCT00154024
IKPD 03-02

Details and patient eligibility

About

Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.

Full description

Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.

Sex

Male

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

* healthy subjects * no relevant disease * amendment: hypercholesterolaemic subjects

Exclusion criteria

* any relevant disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems